Lymphedema Caused by Infections Cellulitis and Erysipelas
------------
Persistent Periorbital and Facial Lymphedema Associated With Group A beta-Hemolytic Streptococcal Infection (Erysipelas).
Ophthal Plast Reconstr Surg. 2007 March/April Buckland GT 3rd, Carlson JA, Meyer DR. *Department of Ophthalmology; and daggerPathology, Division of Dermatology and Dermatopathology, Albany Medical College, Albany, New York, U.S.A.
Chronic lymphedema is both a risk factor for and consequence of erysipelas (cellulitis). We report a case of a 62-year-old woman with rheumatoid arthritis treated with etanercept and prednisone, who developed chronic periorbital lymphedema 2 months after Group A beta- hemolytic streptococcus infection of the face. She had significant ptosis OS and thickened, hyperpigmented periorbital skin. Biopsies were consistent with chronic lymphedema. Of note, on 6 months follow- up, the patient's appearance was improved though she still had residual ptosis. A period of extended observation may be warranted in these cases. PMID: 17413641
*********
Edema as a risk factor for multiple episodes of cellulitis/erysipelas of the lower leg
Date: 4/9/07 9:36 AM EST
2006 Nov CLINICAL AND LABORATORY INVESTIGATIONS Cox NH. Dermatology Department, Cumberland Infirmary, Carlisle CA2 7HY, UK. neil.cox@ncumbria-acute.nhs.uk
BACKGROUND: Cellulitis of the lower leg is a common problem with considerable morbidity. Risk factors are well identified but the relationship between consequences of cellulitis and further episodes is less well understood.
OBJECTIVES: To review risk factors, treatment and complications in patients with lower leg cellulitis, to determine the frequency of long-term complications and of further episodes, and any relationship between them, and to consider the likely impact of preventive strategies based on these results.
METHODS: Patients with ascending, presumed streptococcal, cellulitis of the lower leg were identified retrospectively from hospital coding. Hospital records, together with questionnaires to both general practitioners and patients, were used to record subsequent complications and identifiable risk factors for further episodes.
RESULTS: Of 171 patients, 81 (47%) had recurrent episodes and 79 (46%) had chronic oedema. The concurrence of these two factors was strongly correlated.
CONCLUSIONS: This study demonstrates that the true frequency of postcellulitic oedema, as well as that of further episodes, is probably underestimated. Furthermore, there is a strong association between these factors, each of which is both a risk factor for, and a consequence of, each other, and for which intervention (reduction of oedema or more prolonged antibiotic therapy) may reduce the risk of recurrent infection. By contrast, self-reporting of toeweb maceration is low, so attempts to reduce the risk of recurrent cellulitis by treatment of tinea pedis or bacterial intertrigo may fail.
*********
Persistent Periorbital and Facial Lymphedema Associated With Group A beta-Hemolytic Streptococcal Infection (Erysipelas).
Ophthal Plast Reconstr Surg. 2007 March/April
Buckland GT 3rd, Carlson JA, Meyer DR. *Department of Ophthalmology; and daggerPathology, Division of Dermatology and Dermatopathology, Albany Medical College, Albany, New York, U.S.A.
Chronic lymphedema is both a risk factor for and consequence of erysipelas (cellulitis). We report a case of a 62-year-old woman with rheumatoid arthritis treated with etanercept and prednisone, who developed chronic periorbital lymphedema 2 months after Group A beta- hemolytic streptococcus infection of the face. She had significant ptosis OS and thickened, hyperpigmented periorbital skin. Biopsies were consistent with chronic lymphedema. Of note, on 6 months follow- up, the patient's appearance was improved though she still had residual ptosis. A period of extended observation may be warranted in these cases.
